Page last updated: 2024-08-23

4-methoxyamphetamine and Wallerian Degeneration

4-methoxyamphetamine has been researched along with Wallerian Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Callaghan, PD; Daws, LC; Irvine, RJ; Javors, MA; Jones, DJ; Owens, WA; Sanchez, TA	1

Other Studies

1 other study(ies) available for 4-methoxyamphetamine and Wallerian Degeneration

Article	Year
In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function. Journal of neurochemistry, 2007, Volume: 100, Issue:3 Topics: Amphetamines; Animals; Binding, Competitive; Hippocampus; Male; Metabolic Clearance Rate; N-Methyl-3,4-methylenedioxyamphetamine; Presynaptic Terminals; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Wallerian Degeneration	2007

Article

Year

In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.

Journal of neurochemistry, 2007, Volume: 100, Issue:3

Topics: Amphetamines; Animals; Binding, Competitive; Hippocampus; Male; Metabolic Clearance Rate; N-Methyl-3,4-methylenedioxyamphetamine; Presynaptic Terminals; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Wallerian Degeneration

2007